• Thurs news: AbbVie Parkinson’s drug. Arch raises $3B biotech fund. Biogen dropping failed Sage tremor drug. AZ gets sought-after Tagrisso OK. Pfizer withdrawing sickle cell med. See more on our front page

Talk started last year?

Anonymous

Guest
Ex-BoE man highlights alleged ‘insider trading bonanza’ at Astra

by Robert St George*Apr 30, 2014 at 14:58

A former senior adviser to the Bank of England has highlighted unusual trading patterns in*AstraZeneca*before it publicly disclosed a takeover approach from Pfizer.

AstraZeneca revealed on Monday that Ian Read, chairman and chief executive of Pfizer, had first contacted it on 25 November 2013 to ‘discuss a combination’.

AstraZeneca subsequently staged ‘an exploratory meeting’ with Pfizer on 5 January 2014 in New York. Neither event was announced to markets.
 

<